Cargando…

P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS

Detalles Bibliográficos
Autores principales: Duan, Minghui, MA, Lan, Wu, Qiuling, Liang, Hong, Wang, Wei, Wu, Shaoling, Mu, Lijun, Lin, Hai, Zhou, Hebing, Shi, Hongxia, Jing, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431544/
http://dx.doi.org/10.1097/01.HS9.0000971104.15697.cd
_version_ 1785091226605715456
author Duan, Minghui
MA, Lan
Wu, Qiuling
Liang, Hong
Wang, Wei
Wu, Shaoling
Mu, Lijun
Lin, Hai
Zhou, Hebing
Shi, Hongxia
Jing, Hongmei
author_facet Duan, Minghui
MA, Lan
Wu, Qiuling
Liang, Hong
Wang, Wei
Wu, Shaoling
Mu, Lijun
Lin, Hai
Zhou, Hebing
Shi, Hongxia
Jing, Hongmei
author_sort Duan, Minghui
collection PubMed
description
format Online
Article
Text
id pubmed-10431544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315442023-08-17 P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS Duan, Minghui MA, Lan Wu, Qiuling Liang, Hong Wang, Wei Wu, Shaoling Mu, Lijun Lin, Hai Zhou, Hebing Shi, Hongxia Jing, Hongmei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431544/ http://dx.doi.org/10.1097/01.HS9.0000971104.15697.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Duan, Minghui
MA, Lan
Wu, Qiuling
Liang, Hong
Wang, Wei
Wu, Shaoling
Mu, Lijun
Lin, Hai
Zhou, Hebing
Shi, Hongxia
Jing, Hongmei
P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title_full P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title_fullStr P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title_full_unstemmed P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title_short P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
title_sort p1052: a real-world study to evaluate the efficacy and safety of selinexor in combination with ruxolitinib in patients with myelofibrosis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431544/
http://dx.doi.org/10.1097/01.HS9.0000971104.15697.cd
work_keys_str_mv AT duanminghui p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT malan p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT wuqiuling p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT lianghong p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT wangwei p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT wushaoling p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT mulijun p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT linhai p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT zhouhebing p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT shihongxia p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis
AT jinghongmei p1052arealworldstudytoevaluatetheefficacyandsafetyofselinexorincombinationwithruxolitinibinpatientswithmyelofibrosis